查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1766962

全球糖尿病診斷市場

Diabetes Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 609 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球糖尿病診斷市場規模將達到 594 億美元

全球糖尿病診斷市場規模預計在2024年為363億美元，預計到2030年將達到594億美元，在2024-2030年的分析期間內，複合年成長率為8.5%。作為本報告分析的細分市場之一，試紙市場預計將以8.7%的複合年成長率成長，到分析期結束時達到147億美元。採血針市場預計在分析期間以7.9%的複合年成長率成長。

美國市場規模估計為 137 億美元，中國市場預計複合年成長率為 10.1%

美國糖尿病診斷市場規模預計2024年達到137億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到76億美元，在2024-2030年的分析期間內，複合年成長率為10.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為7.0%和7.5%。在歐洲，預計德國市場的複合年成長率約為8.6%。

全球糖尿病診斷市場趨勢及促進因素概述

糖尿病診斷藥物的範圍是什麼？為什麼它很重要？

糖尿病診斷涵蓋一系列用於檢測和監測以高血糖為特徵的代謝異常（通常稱為糖尿病）的測試和技術。早期準確的診斷對於有效管理糖尿病和預防許多相關的健康併發症（包括心臟病、腎衰竭和視力問題）至關重要。傳統的診斷工具包括空腹血糖測試、測量 2-3 個月內血糖濃度的 HbA1c 測試以及口服葡萄糖耐受測試。最近的進展擴大了範圍，包括連續血糖監測系統 (CGMS) 和閃光血糖監測儀，它們可以即時洞察血糖血糖濃度，從而實現更有活力的糖尿病管理。全球糖尿病盛行率的不斷上升使得廣泛使用這些診斷工具成為必要，以減輕其帶來的巨大健康和經濟負擔。

技術創新如何改變糖尿病診斷？

技術創新正在徹底改變糖尿病診斷，使血糖值監測更加便利、快速且侵入性更低。感測器技術和數位健康平台的最新發展催生了穿戴式設備，這些設備可以持續追蹤血糖濃度，無需頻繁用手指操作。這些設備透過皮下植入的微型感測器測量組織間液中的葡萄糖濃度，並將數據發送至智慧型手機或專用讀取器，從而提供血糖趨勢和波動的即時回饋。此外，人工智慧 (AI) 與糖尿病護理的融合增強了監測設備的預測能力，透過分析使用者數據以及飲食、運動等外部因素，有助於預測和預防高血糖和低血糖事件。這些進步不僅改善了個體預後，還透過促進不同族群糖尿病的早期發現和持續管理，為更廣泛的公共衛生策略做出了貢獻。

影響糖尿病診斷實踐的新興趨勢

一些新興趨勢正在重塑糖尿病診斷領域的臨床實踐。個人化醫療正變得越來越普遍，根據個人基因圖譜客製化診斷以預測疾病風險並進行相應治療。這種方法以數據分析和機器學習的發展為基礎，它們有助於解釋大型資料集以發現有助於制定更好治療通訊協定的模式。此外，人們開始轉向綜合護理模式，將診斷工具作為糖尿病管理整體方法的一部分，其中還包括飲食、運動和心理健康。消費者健康科技趨勢也很重要，越來越多的患者使用行動醫療應用程式和連網裝置來獨立管理自己的病情。這些趨勢強調了向以患者為中心和數據主導的護理轉變，增強了患者的能力並提高了醫療服務的效率。

什麼因素推動了糖尿病診斷市場的成長？

糖尿病診斷市場的成長受到多種因素的推動，其中包括人口老化和肥胖率上升導致全球糖尿病盛行率上升。人們意識的提高和篩檢項目的加強正在提高診斷率，從而刺激了對監測和診斷產品的需求。此外，能夠提高準確性、便利性和連接性的技術進步也至關重要，這滿足了患者對能夠無縫融入其生活方式並提供即時回饋以有效管理健康的設備的需求。此外，醫療保健提供者不斷尋求經濟有效的方法來管理和治療包括糖尿病在內的慢性疾病，這支持了對創新診斷解決方案的持續投資。此外，新興市場對新型醫療設備的監管支援以及醫療基礎設施的不斷擴展也促進了該行業的強勁成長。這些動態凸顯了創新和適應在滿足全球醫療保健領域日益成長的需求方面發揮的關鍵作用。

部分

產品類型（試紙、採血針、模擬血糖儀、連續血糖儀、注射器、筆、幫浦、注射器）、最終用戶（醫院、居家醫療、診斷中心、其他最終用戶）

受訪公司範例

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • A. Menarini Diagnostics Srl
  • AgaMatrix, Inc.
  • BIONIME Corporation
  • Ascensia Diabetes Care Holdings AG
  • American Laboratory Products Company（ALPCO）
  • AmbiMedInc
  • Companion Medical, Inc.
  • Ciga Healthcare Ltd.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP-3404

Global Diabetes Diagnostics Market to Reach US$59.4 Billion by 2030

The global market for Diabetes Diagnostics estimated at US$36.3 Billion in the year 2024, is expected to reach US$59.4 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Test Strips, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$14.7 Billion by the end of the analysis period. Growth in the Lancets segment is estimated at 7.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.7 Billion While China is Forecast to Grow at 10.1% CAGR

The Diabetes Diagnostics market in the U.S. is estimated at US$13.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.6 Billion by the year 2030 trailing a CAGR of 10.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR.

Global Diabetes Diagnostics Market - Key Trends & Drivers Summarized

What Is the Scope of Diabetes Diagnostics and Why Is It Crucial?

Diabetes diagnostics encompass a range of tests and technologies used to detect and monitor the metabolic disorder characterized by high blood glucose levels, commonly referred to as diabetes. Early and accurate diagnosis is crucial to managing diabetes effectively and preventing a plethora of associated health complications such as heart disease, kidney failure, and vision impairment. Traditional diagnostic tools include fasting blood sugar tests, HbA1c tests, which measure glucose levels over two to three months, and oral glucose tolerance tests. Recent advancements have expanded the scope to include continuous glucose monitoring systems (CGMS) and flash glucose monitors, which provide real-time insights into glucose levels, enabling more dynamic management of the disease. The increasing prevalence of diabetes globally necessitates widespread access to these diagnostic tools to mitigate the substantial health and economic burdens posed by the disease.

How Are Technological Innovations Transforming Diabetes Diagnostics?

Technological innovations are significantly transforming diabetes diagnostics, making it easier, faster, and less invasive to monitor blood glucose levels. Modern developments in sensor technology and digital health platforms have led to the creation of wearable devices that track glucose levels continuously without the need for frequent finger-pricking. These devices use tiny sensors inserted under the skin to measure glucose levels in interstitial fluid and provide data to smartphones or dedicated readers, allowing for immediate feedback on glucose trends and variability. Additionally, the integration of artificial intelligence (AI) in diabetes care is enhancing the predictive capabilities of monitoring devices, helping to anticipate and prevent hyperglycemic and hypoglycemic events by analyzing user data and external factors such as diet and exercise. These advancements not only improve individual outcomes but also contribute to broader public health strategies by facilitating the early detection and ongoing management of diabetes in diverse populations.

Emerging Trends Influencing Diabetes Diagnostic Practices

Several emerging trends are reshaping practices within the diabetes diagnostics field. Personalized medicine is becoming increasingly prevalent, with diagnostics tailored to individual genetic profiles to predict disease risk and tailor treatments accordingly. This approach is supported by the growth in data analytics and machine learning, which help in interpreting large datasets to uncover patterns that can inform better treatment protocols. Additionally, there is a growing shift towards integrated care models, where diagnostic tools are part of a holistic approach to diabetes management that includes diet, exercise, and mental health. The consumer health technology trend is also significant, with more patients using mobile health applications and connected devices to manage their condition independently. These trends underscore a move towards more patient-centered and data-driven care, which empowers patients and enhances the efficiency of healthcare delivery.

What Drives the Growth of the Diabetes Diagnostics Market?

The growth in the diabetes diagnostics market is driven by several factors, including the rising global prevalence of diabetes due to aging populations and increasing rates of obesity. Enhanced awareness and better screening programs are leading to higher diagnosis rates, thereby increasing the demand for monitoring and diagnostic products. Technological advancements that offer improved accuracy, convenience, and connectivity are also pivotal, as they address patient demands for devices that fit seamlessly into their lifestyles and provide instant feedback to manage their health effectively. Furthermore, healthcare providers are continuously seeking cost-effective ways to manage and treat chronic diseases, including diabetes, which supports ongoing investment in innovative diagnostic solutions. Additionally, regulatory support for novel medical devices and the expansion of healthcare infrastructure in emerging markets contribute to the robust growth of this sector. These dynamics highlight the critical role of innovation and adaptation in meeting the expanding needs within the global healthcare landscape.

SCOPE OF STUDY:

The report analyzes the Diabetes Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps, Injectors); End-Use (Hospitals, Home Care, Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 91 Featured) -

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • A. Menarini Diagnostics Srl
  • AgaMatrix, Inc.
  • BIONIME Corporation
  • Ascensia Diabetes Care Holdings AG
  • American Laboratory Products Company (ALPCO)
  • AmbiMedInc
  • Companion Medical, Inc.
  • Ciga Healthcare Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Diabetes: A Chronic Body Disorder
    • An Introduction to Diabetes Diagnostics
    • Diabetes Diagnostics: Easier, Economic, and Efficient Management of the Global Diabetes Epidemic
    • Developed Regions Lead, Developing Economies to Spearhead Future Growth
    • Increase in Number of Hospitals & Diagnostics Centers Augurs Well for Market in Developing Regions
    • Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices
    • Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
    • Diabetes Emerges as One of the Leading Causes of Mortality
    • Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region
    • Competition
    • Quality Products at Low Prices: Mantra for Success in the Marketplace
    • SMBG Makers Turn to Mobile Devices to Woo Users on the Move
    • World Brands
    • Recent Market Activity
    • Diabetes Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market
    • World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2024
    • Increasing Obesity Levels Underpins Market Growth
    • Average Per Capita Annual Health Expenditure (In US$) due to Obesity
    • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
    • Rising Importance of Real-Time Glucose Sensing and Monitoring Drive Robust Growth in Minimally-Invasive CGM Devices Market
    • Global Continuous Glucose Monitoring Systems Market by Component for 2024
    • CGM Market Breaks through Barriers to Witness Growing Adoption
    • Growing Role of HbA1c Testing Devices in Monitoring & Management of Diabetes
    • Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market
    • Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
    • Glycated Albumin: A Potential Threat to HbA1c
    • Role of HbA1c Testing in Diabetes Diagnosis and Management
    • HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants
    • Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
    • Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Witness Demand Growth
    • Blood Glucose Strips: Low Cost Advantage Augurs Drives Market
    • Blood Sugar Lancets Market: Sustained Growth in Demand
    • Self-Monitoring/Household Blood Glucose Sustains Market Growth
    • Rising Smartphone Penetration Augurs Well for SMBG Market
    • Smartphone Penetration Rate as Share of Total Population: 2016-2024
    • Barriers to Adoption of New Technology in BGM Products
    • Accuracy Issues Plague Blood Glucose Meters Market
    • Insulin Pens Rise in Popularity for Administering Insulin
    • Smart Insulin Pens
    • Increasing Role of Self-Injection Devices in Diabetes Management
    • Prefilled Syringe Pen Injectors
    • Human Factors Influence the Design of Self Injection Systems
    • Pain Free Shots: A Growing R&D Domain
    • Undiagnosed Diabetes Emerges as a Major Healthcare Challenge, Translates into Untapped Potential for Diabetes Diagnostics Market
    • Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2024
    • Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices
    • Innovations & Product Advancements: Prime Focus Area for Vendors
    • Focus on Development of Wearable Devices
    • An Insight into Intriguing Advances in Blood Glucose Monitoring Techniques
    • Companies Develop Innovative Needle-Free Alternatives
    • mHealth Solutions for Diabetes Diagnosis
    • Non-invasive Wearable Glucose Testing Devices
    • Innovations in Insulin Pumps
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Diabetes Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 3: World 16-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Test Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Test Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 6: World 16-Year Perspective for Test Strips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 9: World 16-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Analog Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Analog Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 12: World 16-Year Perspective for Analog Glucose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Continuous Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Continuous Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 15: World 16-Year Perspective for Continuous Glucose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 18: World 16-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 21: World 16-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 24: World 16-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 27: World 16-Year Perspective for Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 30: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 33: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 36: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 39: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 40: World Diabetes Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • With Diabetes Emerging as a Major Lifestyle Disease, Diabetes Diagnostics Market Poised for Growth in the US
    • Diabetes and Population Statistics in North America and Caribbean Region (2019, 2030 & 2045)
    • Diabetes Prevalence by Ethnicity
    • Aging Demographics: A Factor Driving Diabetes Prevalence
    • Population of 65+ Age Group (in Thousands) in the US for 2019 and 2030
    • North American Aging Population (in Thousands) by Age Group: 1975-2050
    • Diabetes Prevalence in the US: Percentage Share Breakdown of Number of Diabetics by Age Group
    • Rising Significance of Wearable and Non-Invasive Glucose Monitoring Devices
    • Regulatory Guidance for Glucose Meter Companies
    • Insulin Syringes Dominate the Insulin Delivery Devices Market
    • Emerging Grey Market for Testing Strips
    • Competition
    • Companies Focus on Research for Better Diabetes Diagnostics
    • TABLE 41: USA Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • Rising Diabetes Incidence in Canada: Opportunity for Diabetes Diagnostics Market
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • Aging Population Drives Diabetes Diagnostics Market
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • Increasing Diabetes Incidence Drives Market Growth
    • Lower Penetration Offers High Growth Potential
    • TABLE 59: China Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: China 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • Diabetes Diagnostics Market in Europe: A Promising Outlook
    • Diabetes and Population Statistics in Europe (2019, 2030 & 2045)
    • Reimbursement Scenario
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Diabetes Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: France 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: UK 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
    • Market Overview
    • Diabetic Foot Ulcers in UK
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Spain 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Russia 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • Asia-Pacific: Rising Diabetes Incidence Offers Significant Growth Opportunities
    • Diabetes and Population Statistics in South East Asia (2019 & 2045)
    • Diabetes and Population Statistics in Western Pacific (2019 & 2045)
    • Public and Private Sector Diabetes Care
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Diabetes Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Australia 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • Expanding Diabetic Population Spurs Growth in the Indian Market
    • Blood Glucose Monitoring Market: An Overview
    • HbA1c Testing Continues to Gain Momentum
    • Glucose Meters Rely on Imported Technology
    • TABLE 131: India Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: India 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: India 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: South Korea 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • Rising Diabetes Cases Present Opportunities for Diabetes Diagnostics in Latin America
    • Diabetes and Population Statistics in South & Central America (2019 & 2045)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Diabetes Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Latin America 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Argentina 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Brazil 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Mexico 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Rest of Latin America 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Diabetes Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Middle East 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Iran 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Israel 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Saudi Arabia 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: UAE 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Rest of Middle East 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Africa 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION